Correlation between overall survival and other endpoints in clinical trials of second-line chemotherapy for patients with advanced gastric cancer

Author： Shitara Kohei Matsuo Keitaro Muro Kei Doi Toshihiko Ohtsu Atsushi

Publisher： Springer Publishing Company

ISSN： 1436-3291

Source： Gastric Cancer, Vol.17, Iss.2, 2014-04, pp. : 362-370

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Second-line chemotherapy for advanced gastric cancer in Korea

By Baek Sun Kim Si-Young Jeong Jae-heon Cho Kyung Yoon Hwi-Joong

Gastric Cancer, Vol. 15, Iss. 4, 2012-10 ,pp. : 345-354

Springer Publishing Company

Access to resources Recommend Favorite

A clinical study of docetaxel with or without 5′DFUR as a second-line chemotherapy for advanced gastric cancer

By Maruta Fukuto Ishizone Satoshi Hiraguri Manabu Fujimori Yoshiro Shimizu Fumiaki Kumeda Shigeyoshi Miyagawa Shinichi

Medical Oncology, Vol. 24, Iss. 1, 2007-01 ,pp. : 71-75

Humana Press, Inc

Access to resources Recommend Favorite

Availability of irinotecan in a second-line setting confers survival benefit to patients with advanced gastric cancer refractory to fluoropyrimidine-based regimens

Oncology Letters, Vol. 2, Iss. 2, 2011-01 ,pp. : 247-251

Spandidos Publications

Access to resources Recommend Favorite

Docetaxel and oxaliplatin combination in second-line treatment of patients with advanced gastric cancer

By Barone Carlo Basso Michele Schinzari Giovanni Pozzo Carmelo Trigila Nunziatina D'Argento Ettore Quirino Michela Astone Antonio Cassano Alessandra

Gastric Cancer, Vol. 10, Iss. 2, 2007-06 ,pp. : 104-111

Springer Publishing Company

Access to resources Recommend Favorite

Second-line chemotherapy for gastric cancer: a new issue lies ahead in global trials

By Takiuchi Hiroya

Gastric Cancer, Vol. 14, Iss. 3, 2011-08 ,pp. : 206-211

Springer Publishing Company

Access to resources Recommend Favorite